Out-of-pocket costs for branded drugs to treat multiple sclerosis (MS), Alzheimer's, and Parkinson's disease rose from 2012 ...

Q3 2024 Earnings Call Transcript November 7, 2024 ClearPoint Neuro, Inc. misses on earnings expectations. Reported EPS is $-0 ...

President Bola Tinubu has approved the reappointment of Dr Afis Agboola as the Provost and Medical Director of the Federal ...

EST ClearPoint Neuro (CLPT) trading halted, volatility trading pause Published first on TheFly – the ultimate source for ...

Lake Street raised the firm’s price target on ClearPoint Neuro (CLPT) to $17 from $15 and keeps a Buy rating on the shares. Q3 outperformance was driven by another quarter of broad-business strength, ...

ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -5.88% and 0.64%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

City’s famous neuro-surgeon and organising secretary Dr Rupesh Khatri told reporters that the special medical conference will ...

ClearPoint Neuro develops and commercializes platforms for performing minimally invasive surgical procedures in the brain.

Ultragenyx Pharmaceutical (RARE) shows promising results for GTX-102 in Angelman syndrome Phase 1/2 trial, supporting a Phase ...

David Harrington, CEO of Centre for Neuro Skills, discusses the need for specialized treatment for brain injury patients with ...

While stroke is a global issue, India’s vulnerability to it is alarming — studies reveal that a new stroke occurs every 40 ...

Sense Neuro Diagnostics, a leader in developing technology for the diagnosis and monitoring of brain injuries, today announced it has been awarded a $2 million contract by the Department of Defense ...